U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. HAVRIX
  1. Vaccines

STN: BL 103475
Proper Name: Hepatitis A Vaccine
Tradename: HAVRIX
Manufacturer: GlaxoSmithKline Biologicals
Indication:

  • HAVRIX is indicated for active immunization against disease caused by hepatitis A virus (HAV).
  • HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV.

Product Information

Supporting Documents

Back to Top